Harold B. Eiber

510 total citations
26 papers, 330 citations indexed

About

Harold B. Eiber is a scholar working on Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Harold B. Eiber has authored 26 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Harold B. Eiber's work include Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Harold B. Eiber is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Harold B. Eiber collaborates with scholars based in United States and Germany. Harold B. Eiber's co-authors include I. Danishefsky, Leo Loewe, Alton Goldbloom, Linn J. Boyd, B. Goldberg and Jianli Sang and has published in prestigious journals such as Nature, JAMA and Journal of Biological Chemistry.

In The Last Decade

Harold B. Eiber

25 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold B. Eiber United States 11 146 127 73 47 30 26 330
H Leipold United States 11 80 0.5× 117 0.9× 15 0.2× 86 1.8× 29 1.0× 15 428
Ototaka Higashi Japan 10 39 0.3× 101 0.8× 12 0.2× 18 0.4× 17 0.6× 30 408
J. Lansen Italy 11 53 0.4× 113 0.9× 15 0.2× 31 0.7× 6 0.2× 18 317
Z. Stary Türkiye 10 70 0.5× 114 0.9× 54 0.7× 19 0.4× 18 0.6× 30 267
R Nicolás Spain 8 57 0.4× 87 0.7× 43 0.6× 29 0.6× 5 0.2× 19 408
D.P. Groth United States 14 25 0.2× 192 1.5× 15 0.2× 11 0.2× 38 1.3× 24 349
C. A. L. Stephens United States 9 33 0.2× 69 0.5× 9 0.1× 14 0.3× 8 0.3× 19 289
Zelma Baker Miller United States 7 24 0.2× 97 0.8× 12 0.2× 21 0.4× 12 0.4× 13 250
Marvin B. Goldlust United States 11 19 0.1× 70 0.6× 10 0.1× 29 0.6× 11 0.4× 22 322
Hideo Shirafuji Japan 10 18 0.1× 219 1.7× 44 0.6× 20 0.4× 7 0.2× 17 464

Countries citing papers authored by Harold B. Eiber

Since Specialization
Citations

This map shows the geographic impact of Harold B. Eiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold B. Eiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold B. Eiber more than expected).

Fields of papers citing papers by Harold B. Eiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold B. Eiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold B. Eiber. The network helps show where Harold B. Eiber may publish in the future.

Co-authorship network of co-authors of Harold B. Eiber

This figure shows the co-authorship network connecting the top 25 collaborators of Harold B. Eiber. A scholar is included among the top collaborators of Harold B. Eiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold B. Eiber. Harold B. Eiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eiber, Harold B., et al.. (1966). Studies on plasma clearing factor II. Substrates. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 116(2). 256–263. 5 indexed citations
2.
Eiber, Harold B., et al.. (1966). Studies with Clearing Factor III. Application of Column and Thin Layer Chromatography for Separation of Lipid Hydrolysis Products By Clearing Factor.. Experimental Biology and Medicine. 122(2). 509–512. 1 indexed citations
3.
Eiber, Harold B., et al.. (1964). Verfahren und Einrichtung zur quantitativen Bestimmung der Oxydationsinsuffizienz bei Stoffwechselerkrankungen. Journal of Molecular Medicine. 42(4). 176–180. 2 indexed citations
4.
Eiber, Harold B., et al.. (1964). ISOLATION AND PURIFICATION OF THE CLEARING FACTOR OF POSTHEPARIN HUMAN PLASMA.. PubMed. 63. 425–30. 1 indexed citations
5.
Danishefsky, I., et al.. (1962). Investigations on the Chemistry of Heparin. Journal of Biological Chemistry. 237(5). 1413–1417. 19 indexed citations
6.
Eiber, Harold B.. (1961). Quantitative Studies on the Clearing Effect of Heparin. JAMA. 176(10). 871–871. 4 indexed citations
7.
Danishefsky, I., et al.. (1960). Investigations on the chemistry of heparin. II. presence of a uronidic linkage with carbon-6 of glucosamine. Biochemical and Biophysical Research Communications. 3(6). 571–574. 10 indexed citations
8.
Danishefsky, I., et al.. (1960). Investigations on the chemistry of heparin. I. Desulfation and acetylation. Archives of Biochemistry and Biophysics. 90(1). 114–121. 71 indexed citations
9.
Eiber, Harold B., et al.. (1960). Studies Made With Radioactive Heparin in Humans. Angiology. 11(1). 40–43. 24 indexed citations
10.
Danishefsky, I. & Harold B. Eiber. (1959). Studies on the metabolism of heparin. Archives of Biochemistry and Biophysics. 85(1). 53–61. 37 indexed citations
11.
Eiber, Harold B.. (1958). Synthesis and Metabolism of Radioactive Heparin. Archives of Internal Medicine. 102(2). 189–189. 15 indexed citations
12.
Eiber, Harold B. & I. Danishefsky. (1957). Heparin in Blood.. Experimental Biology and Medicine. 94(4). 801–802. 16 indexed citations
13.
Eiber, Harold B., et al.. (1957). THE INCORPORATION OF S35-SULFATE INTO HEPARIN. Journal of Biological Chemistry. 226(2). 721–724. 15 indexed citations
14.
Goldbloom, Alton, Harold B. Eiber, & Linn J. Boyd. (1956). NEWER CLINICAL AND LABORATORY STUDIES IN THE AGED. XIII. GENERAL MANAGEMENT OF NORMAL INDIVIDUALS AFTER THE AGE OF 80††. Journal of the American Geriatrics Society. 4(6). 599–608. 3 indexed citations
15.
Eiber, Harold B., Jianli Sang, & I. Danishefsky. (1956). Free Electrophoresis of Lipoproteins. Experimental Biology and Medicine. 92(4). 700–703. 1 indexed citations
16.
Eiber, Harold B.. (1955). Chlorpromazine (Thorazine) — Rauwolfia Combination in Neuropsychiatry. A M A Archives of Neurology & Psychiatry. 74(1). 36–36. 4 indexed citations
17.
Goldbloom, Alton, et al.. (1955). Evaluation of clinical methods in gastrointestinal diseases. VII. Tubeless detection of gastric acidity using an azure a ion-exchange indicator. The American Journal of Digestive Diseases. 22(10). 288–291. 7 indexed citations
18.
Eiber, Harold B.. (1955). COMBINED CHLORPROMAZINE-RAUWOLFIA SERPENTINA THERAPY IN ESSENTIAL HYPERTENSION. Journal of the American Medical Association. 158(9). 730–730. 10 indexed citations
19.
Goldbloom, Alton, Harold B. Eiber, & Linn J. Boyd. (1954). Clinical studies in blood lipid metabolism. IX. Effect of lipotropic agents on serum lipid partitions in fifty patients with generalized atherosclerosis: A three year study. The American Journal of Digestive Diseases. 21(6). 152–157. 4 indexed citations
20.
Loewe, Leo, et al.. (1951). THERAPY OF SUBACUTE ENTEROCOCCUS (STREPTOCOCCUS FECALIS) ENDOCARDITIS. Annals of Internal Medicine. 34(3). 717–736. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026